Glial cell line-derived neurotrophic factor: Distribution and pharmacology in the rat following a bolus intraventricular injection

Brain Research

Volumn 747, Issue 1, 1997, Pages 92-102

  Lapchak, Paul A ^a   Jiao, Shoushu ^a   Collins, Frank ^a   Miller, Paul J ^a  

^a AMGEN INC   (United States)

Author keywords

Alzheimer's disease; basal ganglia; cholinergic function; dopamine; glial cell line derived neurotrophic factor; neurotrophic factor; Parkinson's disease

Indexed keywords

DIHYDROXYPHENYLACETIC ACID; DOPAMINE; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; HOMOVANILLIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BASAL GANGLION; BRAIN REGION; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE UPTAKE; FEMALE; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; SUBSTANTIA NIGRA;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; BRAIN CHEMISTRY; DOPAMINE; FEMALE; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; HOMOVANILLIC ACID; INJECTIONS, INTRAVENTRICULAR; IODINE RADIOISOTOPES; NERVE GROWTH FACTORS; NERVE TISSUE PROTEINS; RATS; RATS, WISTAR; TISSUE DISTRIBUTION;

EID: 0031041936     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(96)01265-6     Document Type: Article

References (41)

1. Abercrombie, E.D. and Zigmond, M.J., Partial injury to central noradrenergic neurons: reduction of tissue norepinephrine content is greater than reduction of extracellular norepinephrine measured by microdialysis, J. Neurosci., 9 (1989) 4062-4067.
2. Bowenkamp, K.E., Lapchak, P.A., Hoffer, B.J. and Bickford, P.C., Glial cell line-derived neurotrophic factor reverses motor impairment in 16-17 month old rats, Neurosci. Lett., 211 (1996) 81-84.
3. Bowenkamp, K.E., Hoffman, A.F., Gerhardt, G.A., Henry, M.A., Biddle, P.T., Hoffer, B.J. and Granholm, A.E., Glial cell line-derived neurotrophic factor supports survival of injured midbrain dopaminergic neurons, J. Comp. Neurol., 355 (1995) 479-489.
4. Bowenkamp, K.E., David, D., Lapchak, P.A., Henry, M.A., Granholm, A.C., Hoffer, B.J. and Mahalik, T.J., 6-Hydroxydopamine induced the loss of the dopaminergic phenotype in substantia nigra neurons in the rat, Exp. Brain. Res. (1996) in press.
5. DiStefano, P.S., Friedman, B., Radziejewski, C., Alexander, C., Boland, P., Schick, C.M., Lindsay, R.M. and Wiegand, S.J., The neurotrophins BDNF, NT-3, and NGF display distinct patterns of retrograde axonal transport in peripheral and central neurons, Neuron, 8 (1992) 983-993.
6. Gash, D.M., Zhang, Z., Cass, W.A., Ovadia, A., Simmerman, L., Martin, D., Russell, D., Collins, F., Hoffer, B.J. and Gerhardt, G.A., Morphological and functional effects of intranigrally administered GDNF in normal rhesus monkeys, J. Comp. Neurol., 363 (1995) 345-358.
7. Gash, D.M., Zhang, Z., Ovadia, A., Cass, W.A, Yi, A., Simmerman, L., Russell, D., Martin, D., Lapchak, P.A., Collins, F., Hoffer, B.J. and Gerhardt, G.A., GDNF promotes functional recovery in parkinsonian monkeys, Nature, 380 (1996) 252-255.
8. Gillard, E.R., Dang, D.Q. and Stanley, B.G., Evidence that neuropeptide Y and dopamine in the perifornical hypothalamus interact antagonistically in the control of food intake, Brain Res., 628 (1993) 128-136.
9. + evoked overflow of dopamine in rat striatum, Soc. Neurosci. Abstr., 21 (1995) 541.
10. Hoffer, B.J., Hoffman, A., Bowenkamp, K., Huettl, P., Hudson, J., Martin, D., Lin, L.F.H. and Gerhardt, G., Glial cell line-derived neurotrophic factor reverses toxin-induced injury to midbrain dopaminergic neurons in vivo, Neurosci. Lett., 182 (1994) 107-111.
11. Hou, J.G.G., Lin, L.F.H. and Mytilineou, C., Glial cell line-derived neurotrophic factor exerts neurotrophic effects on dopaminergic neurons in vitro and promotes their survival and regrowth after damage by 1-methyl-4-phenylpyridinium, J. Neurochem., 66 (1996) 74-82.
12. Hornykiewicz, O. and Fish, S.J., Biochemical pathophysiology in Parkinson's disease, Adv. Neurol., 45 (1986) 19-34.
13. Hudson, J., Granholm, A.C., Gerhardt, G.A., Henry, M.A., Hoffman, A., Biddle, P., Leele, N.S., Mackerlova, L., Lile, J.D., Collins, F. and Hoffer, B.J., Glial cell line-derived neurotrophic factor augments midbrain dopaminergic circuits in vivo, Brain Res. Bull., 36 (1995) 425-432.
14. Kearns, C. and Gash, D.M., GDNF protects nigral dopamine neurons against 6-hydroxydopamine in vivo, Brain Res., 672 (1995) 104-111.
15. Koliatosos, V.E. and Price, D.L., Retrograde axonal transport: Applications in trophic factor research. In A. Boulton, G. Baker and F. Hefti (Eds.), Neuromethods, Vol. 25: Neurotrophic Factors, Humana Press, Totawa, NJ, 1993, pp. 247-277.
16. Koller, W.C. and Hubble, J.P., Levodopa therapy in Parkinson's disease, Neurology, 40 (1990) 40-47.
17. Kupsch, A., Oertel, W.H., Earl, C.D. and Sautter, J., Neuronal transplantation and neurotrophic factors in the treatment of Parkinson's disease - update February 1995, J. Neural Transm. (Suppl.), 46 (1995) 193-207.
18. Lapchak, P.A., Jenden, D.J. and Hefti, F., Compensatory elevation of acetylcholine synthesis in vivo by cholinergic neurons surviving partial lesions of the septohippocampal pathway, J. Neurosci., 11 (1991) 2821-2828.
19. Lapchak, P.A. and Hefti, F., BDNF and NGF treatment of lesioned rats: effect on cholinergic function and weight gain, NeuroReport, 3 (1992) 405-408.
20. Lapchak, P.A., Araujo, D.M. and Hefti, F., Neurotrophins in the central nervous system, Rev. Neurosci., 3 (1992) 1-10.
21. Lapchak, P.A. and Araujo, D.M., NGF supression of weight gain in adult female rats correlates with decreased hypothalamic cholecystokinin levels, Brain Res., 655 (1994) 12-16.
22. Lapchak, P.A., Therapeutic potentials for glial cell line-derived neurotrophic factor (GDNF) based upon pharmacological activities in the CNS, Rev. Neurosci., 7 (1996) 165-176.
23. Lapchak, P.A., Jiao, S.S., Miller, P.J., Williams, L.R., Cummins, V., Inouye, G., Matheson, C.R. and Yan, Q., Pharmacological characterization of glial cell line-derived neurotrophic factor: implications for GDNF as a therapeutic molecule to treat neurodegenerative diseases, Cell Tissue Res., 286 (1996) 179-189.
24. Lapchak, P.A., Araujo, D.M., Gash, D.M., Hilt, D., Hoffer, B.J. and Collins, F., Glial cell line-derived neurotrophic factor (GDNF): pharmacological activities and application to the treatment of Parkinson's disease, Exp. Neurol. (1996) (in press).
25. Lapchak, P.A., Miller, P.J., Araujo, D.M., Hilt, D. and Collins, F., Biology of glial cell line-derived neurotrophic factor (GDNF): implications for the use of GDNF to treat Parkinson's disease, Neurodegeneration, 5 (1996) 197-205.
26. Lapchak, P.A., Gash, D.M., Jiao, S., Miller, P.J. and Hilt, D., Glial cell line-derived neurotrophic factor: a novel therapeutic approach to treat motor dysfunction in Parkinson's disease, Exp. Neurol., (1996) (in press).
27. 125I]glial cell line-derived neurotrophic factor in unlesioned and MPTP-lesioned rhesus monkeys following an intraventricular injection: apparent labeling of nigral dopaminergic neurons, Exp. Neurol., (submitted).
28. Leenders, K.L., Salmon, E.P., Tyrrell, P., Perani, D., Brooks, D.J., Sager, H., Jones, T., Marsden, D. and Franchowiak, R.S.J., The nigrostriatal dopaminergic system assessed in vivo by positron emission tomography in healthy volunteers and in patients with Parkinson's disease, Arch. Neurol., 47 (1993) 290-1298.
29. Leibowitz, S.F. and Stanley, B.G., Brain peptides and the control of eating behavior. In T.W. Moody (Ed.), Neural and Endocrine Peptides and Receptors, Plenum Press, New York, 1986, pp. 333-352.
30. Lin, L.F., Doherty, D.H., Lile, J.D., Bektesh, S. and Collins, F., GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons, Science, 260 (1993) 1130-1132.
31. Lin, L.F., Zhang, T.J., Collins, F. and Armes, L.G., Purification and initial characterization of rat B49 glial cell line-derived neurotrophic factor, J. Neurochem., 63 (1994) 758-768.
32. 3H]GBR 12935 binding to DA uptake sites: subcellular localization and reduction in Parkinson's disease and progressive supranuclear palsy, Eur. J. Pharmacol., 156 (1988) 331-340.
33. Marsden, C.D. and Parkes, J.D., Success and problems of long-term levodopa therapy in Parkinson's disease, Lancet, 1 (1977) 345-349.
34. Mount, H.T.J., Dean, D.O., Alberch, J., Dreyfus, C.F. and Black, I.E., GDNF promotes the survival and morphologic differentiation of Purkinje cells, Proc. Natl. Acad. Sci. USA, 92 (1995) 9092-9096.
35. Paxinos, G. and Watson, C., The Rat Brain In Stereotaxic Coordinates, 2nd edn., Academic Press, New York, 1992.
36. Seiler, M. and Schwab, M.E., Specific retrograde transport of nerve growth factor (NGF) from neocortex to nucleus basalis in the rat, Brain Res., 300 (1984) 33-39.
37. Tomac, A., Widenfalk, J., Lin, L.F.H., Kohno, T., Ebendal, T., Hoffer, B.J. and Olson, L., Retrograde axonal transport of GDNF in the adult nigrostriatal system supports a trophic role in the adult, Proc. Natl. Acad. Sci. USA, 92 (1995) 8274-8278.
38. Williams, L.R., Inouye, G., Cummins, V. and Pellymounter, M.A., Glial cell line-derived neurotrophic factor sustains axotomized basal forebrain cholinergic neurons in vivo: Dose-response comparison to nerve growth factor and brain-derived neurotrophic factor, J. Pharmacol. Exp. Ther., 211 (1996) 1140-1151.
39. Yan, Q., Matheson, C., Sun, J., Radeke, M.J., Feinstein, S.C. and Miller, J.A., Distribution of intracerebral ventricularly administered neurotrophins in rat brain and its correlation with trk receptor expression, Exp. Neurol., 127 (1994) 23-36.
40. Yan, Q. and Matheson, C., Retrograde transport study of glial cell line-derived neurotrophic factor (GDNF) in adult rat nervous system, Soc. Neurosci. Abstr., 21 (1995) 1301.
41. Zhang, W.Q., Tilson, H.A., Nanry, K.P., Judson, P.M., Hong, J.S. and Stachowiak, M.K., Increased dopamine release from striata of rats after unilateral nigrostriatal bundle damage, Brain Res., 461 (1988) 335-342.